Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of PNT2258 for Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma

This study has been completed.
Information provided by (Responsible Party):
ProNAi Therapeutics, Inc Identifier:
First received: November 20, 2012
Last updated: October 19, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2016
  Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)